A recent nationwide case–control study found that new or continued treatment with systemic, inhaled or intestinal glucocorticoids increased the risk of venous thromboembolism. However, despite efforts to adjust for important covariates, the high potential for residual confounding might invalidate the associations.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Heit, J. A. The epidemiology of venous thromboembolism in the community. Arterioscler. Thromb. Vasc. Biol. 28, 370–372 (2008).
Johannesdottir, S. A. et al. Use of glucocorticoids and risk of venous thromboembolism: a nationwide population-based case-control study. JAMA Intern. Med. 173, 743–752 (2013).
Thygesen, S. K., Christiansen, C. F., Christensen, S., Lash, T. L. & Sorensen, H. T. The predictive value of ICD-10 diagnostic coding used to assess Charlson comorbidity index conditions in the population-based Danish National Registry of Patients. BMC Med. Res. Methodol. 11, 83 (2011).
Severinsen, M. T. et al. Venous thromboembolism discharge diagnoses in the Danish National Patient Registry should be used with caution. J. Clin. Epidemiol. 63, 223–228 (2010).
Grainge, M. J., West, J. & Card, T. R. Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study. Lancet 375, 657–663 (2010).
Merkel, P. A. et al. Brief communication: high incidence of venous thrombotic events among patients with Wegener granulomatosis: the Wegener's Clinical Occurrence of Thrombosis (WeCLOT) Study. Ann. Intern. Med. 142, 620–626 (2005).
Bennett, C. L. et al. Thalidomide- and lenalidomide-associated thromboembolism among patients with cancer. JAMA 296, 2558–2560 (2006).
Blom, J. W. et al. Incidence of venous thrombosis in a large cohort of 66,329 cancer patients: results of a record linkage study. J. Thromb. Haemost. 4, 529–535 (2006).
Caruso, V. et al. Thrombotic complications in adult patients with lymphoma: a meta-analysis of 29 independent cohorts including 18,018 patients and 1,149 events. Blood 115, 5322–5328 (2010).
Payne, J. H. & Vora, A. J. Thrombosis and acute lymphoblastic leukaemia. Br. J. Haematol. 138, 430–445 (2007).
Acknowledgements
J. A. Heit is supported, in part, by grants from the NIH, National Heart, Lung and Blood Institute (R0HL066216, K12HL083797) and by the Mayo Foundation.
Author information
Authors and Affiliations
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Heit, J. Risk of venous thromboembolism with glucocorticoids. Nat Rev Endocrinol 9, 387–388 (2013). https://doi.org/10.1038/nrendo.2013.107
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrendo.2013.107
